Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity

Molecular Immunology

Volumn 44, Issue 9, 2007, Pages 2184-2194

  Brophy, Susan E ^a   Jones, Lindsay L ^a   Holler, Phillip D ^a   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Antigen presentation processing; MHC; T cells

Indexed keywords

ANTIGEN; BREFELDIN A; GLUTAMINYLLEUCYLSERYLPROLYLPHENYLALANYLPROLYLPHENYLALANYLASPARTYLLEUCINE; GLUTAMYLGLUTAMINYLTYROSYLLYSYLPHENYLALANYLTYROSYLSERYLVALINE; LEUCYLSERYLPROLYLPHENYLALANYLPROLYLPHENYLALANYLASPARTYLLEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PEPTIDE DERIVATIVE; PEPTIDE FRAGMENT; SERYLISOLEUCYLISOLEUCYLASPARAGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; SERYLISOLEUCYLTYROSYLARGINYLTYROSYLTYROSYLGLYCYLLEUCINE; T LYMPHOCYTE RECEPTOR; TYROSYLPROLYLHISTIDYLPHENYLALANYLMETHIONYLPROLYLTHREONYLASPARAGINYLLEUCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; CELL CLONE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; BREFELDIN A; CELL LINE, TUMOR; DENDRITIC CELLS; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES; TIME FACTORS;

EID: 33846248827     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.11.016     Document Type: Article

References (55)

1. Ackerman A.L., and Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5 (2004) 678-684
2. Ackerman A.L., Kyritsis C., Tampe R., and Cresswell P. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat. Immunol. 6 (2005) 107-113
3. Alexander J., Payne J.A., Murray R., Frelinger J.A., and Cresswell P. Differential transport requirements of HLA and H-2 class I glycoproteins. Immunogenetics 29 (1989) 380-399
4. Andersen P.S., Stryhn A., Hansen B.E., Fugger L., Engberg J., and Buus S. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc. Natl. Acad. Sci. 93 (1996) 1820-1824
5. Baker M.B., Gagnon J.S., Biddison E.W., and Wiley C.D. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. Immunity 13 (2000) 475-484
6. Bevan M.J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143 (1976) 1283-1288
7. Cai Z., Kishimoto H., Brunmark A., Jackson M.R., Peterson P.A., and Sprent J. Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells. J. Exp. Med. 185 (1997) 641-651
8. Chambers C.A., Sullivan T.J., Truong T., and Allison J.P. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28 (1998) 3137-3143
9. Chefalo P.J., Grandea III A.G., Van Kaer L., and Harding C.V. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol. 170 (2003) 5825-5833
10. Chefalo P.J., and Harding C.V. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH. J. Immunol. 167 (2001) 1274-1282
11. Chlewicki L.K., Holler P.D., Monti B.C., Clutter M.A., and Kranz D.M. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J. Mol. Biol. 346 (2005) 223-239
12. Ciatto C., Tissot A.C., Tschopp M., Capitani G., Pecorari F., Pluckthun A., and Grutter M.G. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides. J. Mol. Biol. 312 (2001) 1059-1071
13. Cohen C.J., Sarig O., Yamano Y., Tomaru U., Jacobson S., and Reiter Y. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies. J. Immunol. 170 (2003) 4349-4361
14. Dadaglio G., Nelson C.A., Deck M.B., Petzold S.J., and Unanue E.R. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6 (1997) 727-738
15. Day P.M., Yewdell J.W., Porgador A., Germain R.N., and Bennink J.R. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8064-8069
16. Degano M., Garcia K.C., Apostolopoulos V., Rudolph M.G., Teyton L., and Wilson I.A. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12 (2000) 251-261
17. Denkberg G., and Reiter Y. Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation. Autoimmun. Rev. 5 (2006) 252-257
18. Freigang S., Egger D., Bienz K., Hengartner H., and Zinkernagel R.M. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13477-13482
19. Garcia K.C., Tallquist M.D., Pease L.R., Brunmark A., Scott C.A., Degano M., Stura E.A., Peterson P.A., Wilson I.A., and Teyton L. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13838-13843
20. Gromme M., Uytdehaag F.G., Janssen H., Calafat J., van Binnendijk R.S., Kenter M.J., Tulp A., Verwoerd D., and Neefjes J. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 10326-10331
21. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., and Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425 (2003) 397-402
22. Hansen T., Balendiran G., Solheim J., Ostrov D., and Nathenson S. Structural features of MHC class I molecules that might facilitate alternative pathways of presentation. Immunol. Today 21 (2000) 83-88
23. Holler P.D., Chlewicki L.K., and Kranz D.M. TCRs with high affinity for foreign pMHC show self-reactivity. Nat. Immunol. 4 (2003) 55-62
24. Holler P.D., Holman P.O., Shusta E.V., O'Herrin S., Wittrup K.D., and Kranz D.M. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5387-5392
25. Holler P.D., and Kranz D.M. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18 (2003) 255-264
26. Holler P.D., Lim A.R., Cho B.K., Rund L.A., and Kranz D.M. CD8-T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. J. Exp. Med. 194 8 (2001) 1043-1052
27. Hornell T.M., Martin S.M., Myers N.B., and Connolly J.M. Peptide length variants p2Ca and QL9 present distinct conformations to L(d)-specific T cells. J. Immunol. 167 (2001) 4207-4214
28. Hornell T.M., Myers N., Hansen T.H., and Connolly J.M. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity. J. Immunol. 170 (2003) 4506-4514
29. Houde M., Bertholet S., Gagnon E., Brunet S., Goyette G., Laplante A., Princiotta M.F., Thibault P., Sacks D., and Desjardins M. Phagosomes are competent organelles for antigen cross-presentation. Nature 425 (2003) 402-406
30. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
31. Kageyama S., Tsomides T.J., Fukusen N., Papayannopoulos I.A., Eisen H.N., and Sykulev Y. Potent cytolytic response by a CD8+ CTL clone to multiple peptides from the same protein in association with an allogeneic class I MHC molecule. J. Immunol. 166 (2001) 3028-3034
32. Krogsgaard M., Prado N., Adams E.J., He X.L., Chow D.C., Wilson D.B., Garcia K.C., and Davis M.M. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell. 12 (2003) 1367-1378
33. Krogsgaard M., Wucherpfennig K.W., Canella B., Hansen B.E., Svejgaard A., Pyrdol J., Ditzel H., Raine C., Engberg J., and Fugger L. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J. Exp. Med. 191 (2000) 1395-1412
34. Kukutsch N.A., Rossner S., Austyn J.M., Schuler G., and Lutz M.B. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells. J. Invest. Dermatol. 115 (2000) 449-453
35. Matsumura M., Fremont D.H., Peterson P.A., and Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257 (1992) 927-934
36. Norbury C.C., Princiotta M.F., Bacik I., Brutkiewicz R.R., Wood P., Elliott T., Bennink J.R., and Yewdell J.W. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J. Immunol. 166 (2001) 4355-4362
37. Palliser D., Guillen E., Ju M., and Eisen H.N. Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells. J. Immunol. 174 (2005) 1879-1887
38. Peng K.-W., Holler P.D., Orr B.A., Kranz D.M., and Russell S.J. Targeting membrane fusion to specific peptide/MHC complexes through a high-affinity T-cell receptor. Gene Ther. 11 (2004) 1234-1239
39. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., and Germain R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6 (1997) 715-726
40. Pu Z., Lovitch S.B., Bikoff E.K., and Unanue E.R. T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 20 (2004) 467-476
41. Reits E., Griekspoor A., Neijssen J., Groothuis T., Jalink K., van Veelen P., Janssen H., Calafat J., Drijfhout J.W., and Neefjes J. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18 (2003) 97-108
42. Rock K.L., and Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17 (1999) 739-779
43. Rock K.L., York I.A., and Goldberg A.L. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5 (2004) 670-677
44. Rudolph M.G., Speir J.A., Brunmark A., Mattsson N., Jackson M.R., Peterson P.A., Teyton L., and Wilson I.A. The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity. Immunity 14 (2001) 231-242
45. d and the T cell receptor. J. Immunol. 157 (1996) 4478-4485
46. Spiotto M.T., Rowley D.A., and Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nat. Med. 10 (2004) 294-298
47. Sykulev Y., Brunmark A., Jackson M., Cohen R.J., Peterson P.A., and Eisen H.N. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1 (1994) 15-22
48. Sykulev Y., Brunmark A., Tsomides T.J., Kageyama S., Jackson M., Peterson P.A., and Eisen H.N. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11487-11491
49. Sykulev Y., Joo M., Vturina I., Tsomides T.J., and Eisen H.N. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4 (1996) 565-571
50. Sykulev Y., Vugmeyster Y., Brunmark A., Ploegh H.L., and Eisen H.N. Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. Immunity 9 (1998) 475-483
51. Tallquist M.D., Weaver A.J., and Pease L.R. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule. J. Immunol. 160 (1998) 802-809
52. Tallquist M.D., Yun T.J., and Pease L.R. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184 (1996) 1017-1026
53. Touret N., Paroutis P., Terebiznik M., Harrison R.E., Trombetta S., Pypaert M., Chow A., Jiang A., Shaw J., Yip C., Moore H.P., van der Wel N., Houben D., Peters P.J., de Chastellier C., Mellman I., and Grinstein S. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123 (2005) 157-170
54. Udaka K., Tsomides T.J., and Eisen H.N. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69 (1992) 989-998
55. Udaka K., Wiesmuller K., Kienle S., Jung G., and Walden P. Self-MHC-restricted peptides recognized by an alloreactive T-lymphocyte clone. J. Immunol. 157 (1996) 670-678